| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000027890 |
| Receipt No. | R000031874 |
| Scientific Title | Registry study of fetal biological signal by new method via maternal abdominal wall using cloud. |
| Date of disclosure of the study information | 2017/06/23 |
| Last modified on | 2019/03/29 (Ver. 4) |
| Basic information | ||
| Public title | Registry study of fetal biological signal by new method via maternal abdominal wall using cloud. | |
| Acronym | Registry study of fetal biological signal by new method via maternal abdominal wall using cloud. | |
| Scientific Title | Registry study of fetal biological signal by new method via maternal abdominal wall using cloud. | |
| Scientific Title:Acronym | Registry study of fetal biological signal by new method via maternal abdominal wall using cloud. | |
| Region |
|
|
| Condition | ||
| Condition | Pregnant woman and their fetus who satisfy following conditions.
1)Age: More than 20 years old (the time of informed consent ) 2) Gestational age: More than 20 weeks but before delivery. |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This research is a registry study to collect measurement raw data including biological signals of fetus and maternal body. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | As a registry study, collecting 100 cases of measurement raw data from fetuses and maternal bodies who are more than 20 weeks but before delivery, and preparing databases for each group of gestational weeks. |
| Key secondary outcomes | 1)Investigate the equivalence between the analyzed results by the cloud and the monitor 138(stand-alone type-device) which was done clinical trial.
2)Evaluate exploratory the potential of clinical application as a fetal ECG, through extracting and analyzing abdominal wall induced fetal electrocardiogram heart rate signal from collected measurement raw data by new fetal heart rate extraction program. 3)When concluded to recognize the potential of clinical application as a fetal ECG, propose the standard value of fetal electrocardiogram, based on data from this study. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Divide the 100 cases into the group of each following number of gestational weeks, to register each group 20 cases as a guide.
Group 1 :: gestational weeks from 20 to 23 Group 2 :: gestational weeks from 24 to 27 Group 3 :: gestational weeks from 28 to 31 Group 4 :: gestational weeks from 32 to 36 Group 5 :: gestational weeks from 37 to 41 |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1)Pregnant woman who is having a prenatal checkup at Tohoku University Hospital.
2) Pregnant woman who agreed the informed consent in Japanese by document, before participants in this study. 3)Pregnant woman who is more than 20 years old.( the time of informed consent). 4)Pregnant woman and fetus, whose gestation ages more than 20 weeks but before delivery. Note) Mother's condition must be stable. It must be one hour or more before delivery. |
|||
| Key exclusion criteria | 1)Pregnant woman who needs legal representative or witness at the informed consent.
2) The socially vulnerable. 3) Pregnant woman and fetus who are judged by a principal research doctor or a research sharing doctor as be inappropriate to participate in this study. |
|||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Tohoku University | ||||||
| Division name | Graduate School of Medicine Disability Science International Disciplinary Biomedical Engineering | ||||||
| Zip code | |||||||
| Address | 9th Floor of the Building No.5 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi | ||||||
| TEL | 022-717-7575 | ||||||
| ykimura@med.tohoku.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Tohoku University | ||||||
| Division name | Graduate School of Medicine, Disability Science International Disciplinary Biomedical Engineering | ||||||
| Zip code | |||||||
| Address | 9th Floor of the Building No.5 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi | ||||||
| TEL | 022-717-7575 | ||||||
| Homepage URL | |||||||
| ykimura@med.tohoku.ac.jp | |||||||
| Sponsor | |
| Institute | Tohoku University Graduate School of Medicine, Disability Science International Disciplinary Biomedical Engineering |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research
And Development |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | 1) To hospital visitor of prenatal checkup, make an explanation of the present study, obtain the consent document.
2) Check whether to meet the selection criteria, perform patient registration. 3) Before or after a prenatal checkup, a pregnant woman is in a state of supine or lying position, using a gel sheet for attachment of dish-shaped electrode code, attach on the abdominal wall maximum 13 electrode codes and an electrode code with an earth for body. 4) At the time of measurement by the test equipment, using the birth surveillance equipment (ultrasonic Doppler method) to observe the condition of fetus, simultaneously collect the data. 5) Measurement must be done more than 10 minutes (About 10 minutes to 20 minutes). |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031874 |